Q1大增135%!传奇生物CAR-T疗法2025有望达20亿美元

药渡
18 Apr

4月15日,强生发布2025一季度财报,营业收入218.93亿美元,同比增长2.4%。其中,研发支出达到了 32.3 亿美元,同时,公司在该季度有重大新产品管线进展,包括 Tremfya 在克罗恩病方面获得批准,Rybrevant/Laz Cluze 在非小细胞肺癌方面的总生存期数据,Icotekinra 在斑块状银屑病方面的数据,以及普通外科机器人系统 Ottava 临床试验的启动。产品方面,...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10